FIELD: medicine. SUBSTANCE: one should additionally inject 2-ethyl-6-methyl-3-oxypyridine succinate for 10 d at the dosage of 400 mg/d: intravenously twice daily at the dosage of 200 ml 0.9%- sodium chloride. The method correlates the main pathogenic links of the disease. EFFECT: higher efficiency of therapy. 1 cl, 2 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CHRONIC ARTERIAL INSUFFICIENCY | 2007 |
|
RU2372088C2 |
METHOD OF TREATING PATIENTS WITH OBLITERATING ARTERIAL SCLEROSIS OF LOWER EXTREMITIES COMBINED WITH ISCHEMIC HEART DISEASE | 2013 |
|
RU2525157C1 |
METHOD OF HYPERLIPIDEMIA TREATMENT | 1994 |
|
RU2054931C1 |
HEPATOPROTECTOR PREPARATION FOR PROPHYLAXIS AND CORRECTION OF TOXIC HEPATIC LESIONS | 2001 |
|
RU2189817C1 |
METHOD OF TREATING OBLITERATING DISEASES OF VESSELS OF LOWER EXTREMITIES | 1992 |
|
RU2014848C1 |
MYELOPROTECTIVE AGENT (3-HYDROXY-6-METHYL-2-ETHYLPYRIDINE SUCCINATE) FOR PROPHYLAXIS AND CORRECTION OF CYTOPENIC SYNDROME | 2001 |
|
RU2193885C1 |
METHOD OF TREATING OBLITERATING ATHEROSCLEROSIS OF ARTERIES OF LOWER EXTREMITIES | 2011 |
|
RU2475275C1 |
METHOD FOR TREATING ATHEROSCLEROTIC ARTERIAL OCCLUSIONS | 1994 |
|
RU2098022C1 |
METHOD FOR ASSESSING RISK OF PROGRESSIVE COURSE OF OBLITERATING ARTERIAL SCLEROSIS OF LOWER EXTREMITIES | 2015 |
|
RU2578968C1 |
METHOD FOR TREATMENT OF HYPERLIPEMIA | 1991 |
|
RU2008821C1 |
Authors
Dates
2002-10-10—Published
2001-06-29—Filed